These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 23212076

  • 1. Dual roles of PKM2 in cancer metabolism.
    Wu S, Le H.
    Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
    [Abstract] [Full Text] [Related]

  • 2. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B, Gottlieb E.
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [Abstract] [Full Text] [Related]

  • 3. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z, Yang P, Li Z.
    Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
    [Abstract] [Full Text] [Related]

  • 4. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
    Li T, Han J, Jia L, Hu X, Chen L, Wang Y.
    Protein Cell; 2019 Aug; 10(8):583-594. PubMed ID: 30887444
    [Abstract] [Full Text] [Related]

  • 5. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S, Liu Q, Liu T, Lu X.
    J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
    [Abstract] [Full Text] [Related]

  • 6. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S, Ji X, Wang R, Miao Y.
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [Abstract] [Full Text] [Related]

  • 7. PKM2 contributes to cancer metabolism.
    Wong N, Ojo D, Yan J, Tang D.
    Cancer Lett; 2015 Jan 28; 356(2 Pt A):184-91. PubMed ID: 24508027
    [Abstract] [Full Text] [Related]

  • 8. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W, Semenza GL.
    Trends Endocrinol Metab; 2012 Nov 28; 23(11):560-6. PubMed ID: 22824010
    [Abstract] [Full Text] [Related]

  • 9. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S.
    Int J Biochem Cell Biol; 2011 Jul 28; 43(7):969-80. PubMed ID: 20156581
    [Abstract] [Full Text] [Related]

  • 10. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
    Tamada M, Suematsu M, Saya H.
    Clin Cancer Res; 2012 Oct 15; 18(20):5554-61. PubMed ID: 23071357
    [Abstract] [Full Text] [Related]

  • 11. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
    Yacovan A, Ozeri R, Kehat T, Mirilashvili S, Sherman D, Aizikovich A, Shitrit A, Ben-Zeev E, Schutz N, Bohana-Kashtan O, Konson A, Behar V, Becker OM.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6460-8. PubMed ID: 22963766
    [Abstract] [Full Text] [Related]

  • 12. Activators of PKM2 in cancer metabolism.
    Warner SL, Carpenter KJ, Bearss DJ.
    Future Med Chem; 2014 Jun 15; 6(10):1167-78. PubMed ID: 25078136
    [Abstract] [Full Text] [Related]

  • 13. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.
    van Niekerk G, Engelbrecht AM.
    Cell Oncol (Dordr); 2018 Aug 15; 41(4):343-351. PubMed ID: 29797241
    [Abstract] [Full Text] [Related]

  • 14. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z, Wang Z, Guo W, Zhang Z, Zhao F, Zhao Y, Jia D, Ding J, Wang H, Yao M, He X.
    Oncogene; 2015 Jul 23; 34(30):3946-56. PubMed ID: 25263439
    [Abstract] [Full Text] [Related]

  • 15. Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance.
    İlhan M.
    Neoplasma; 2022 Jul 23; 69(4):747-754. PubMed ID: 35471978
    [Abstract] [Full Text] [Related]

  • 16. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    He Y, Wang Y, Liu H, Xu X, He S, Tang J, Huang Y, Miao X, Wu Y, Wang Q, Cheng C.
    Leuk Res; 2015 Dec 23; 39(12):1428-36. PubMed ID: 26453405
    [Abstract] [Full Text] [Related]

  • 17. PKM2, a potential target for regulating cancer.
    Li YH, Li XF, Liu JT, Wang H, Fan LL, Li J, Sun GP.
    Gene; 2018 Aug 20; 668():48-53. PubMed ID: 29775756
    [Abstract] [Full Text] [Related]

  • 18. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
    Chen J, Jiang Z, Wang B, Wang Y, Hu X.
    Cancer Lett; 2012 Mar 28; 316(2):204-10. PubMed ID: 22154083
    [Abstract] [Full Text] [Related]

  • 19. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H, Li Z, Yang P, Zhang L, Fan Y, Li Z.
    Cell Signal; 2014 Nov 28; 26(11):2397-405. PubMed ID: 25041845
    [Abstract] [Full Text] [Related]

  • 20. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
    Zhou CF, Li XB, Sun H, Zhang B, Han YS, Jiang Y, Zhuang QL, Fang J, Wu GH.
    IUBMB Life; 2012 Sep 28; 64(9):775-82. PubMed ID: 22807066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.